| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.6 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.7 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.022 | 0.7 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |